Cerner Corporation announced that the CareAware iBus has received CE Marking certification from BSI on the basis of examination under Council Directive 93/42/EEC Annex II Section 3.2. The Cerner CareAware iBus solution connects important medical device information about patient health from disparate systems to the patient’s electronic health record (EHR). This solution will be immediately available to healthcare organizations in the EU allowing them to access medical information from medical devices and EHRs to make informed care decisions. Cerner is transforming healthcare by eliminating error, variance and waste for healthcare providers and consumers around the world. “As a global leader in the development of device connectivity and workflow solutions, we are excited to extend the offering of our CareAware iBus solution into the European market,” said Tom Herzog, Cerner vice president for IT and healthcare devices. “Connecting medical devices to the patient’s EHR supports healthcare interoperability, enabling patients and caregivers to access the right information at the right time.” The Cerner CareAware iBus solution provides additional functionality and workflow benefits. Plug-and-play capabilities for connecting medical devices to any EHR system allow medical devices to connect to the Cerner CareAware iBus much like a USB port that quickly and easily connects peripheral devices to a computer. Once a device is connected, it is immediately recognized and can begin transmitting patient data to the EHR. The solution also allows waveform data to be transmitted directly into the EHR. Clinicians may then analyze the patient’s device data in the context of other clinically relevant data for a specific time period, enabling them to make the best informed care decisions with all relevant information easily accessible from multiple medical devices.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
